Participants and Methods We used a 5% representative sample of Medicare claims data to identify beneficiaries who received a diagnosis of KOA between January 1, 2012, and September 30, 2015, and matched control group without an osteoarthritis (OA) diagnosis. Frequency of 34 comorbid conditions was...
The differential diagnosis of this entity is broad and includes neuroblastoma, embryonal rhabdomyosarcoma, sinonasal undifferentiated, NUT carcinoma, pituitary NETs, paraganglioma, mucosal melanoma, and primitive neuroectodermal tumors. Lineage-associated immunohistochemical markers are needed in the diagnosis and...
Pathology Diagnosis and Molecular Classification to Targeted TherapyAdvances in Experimental RadiotherapyAdvances in Gynecological Oncology: From Pathogenesis to TherapyAdvances in NK/T-cell Lymphoma, Epidemiology, Biology and TherapyAdvances in Our Understanding of ALK-Related Cancers: A Selection of Papers ...
Table 2. Deregulation of SALLs in other cancers. 5.1. Breast Cancer Breast cancer is the most diagnosed tumor and the leading cause of cancer death among women worldwide. Thus, understanding its molecular mechanisms has become necessary for early diagnosis and successful treatment. The intrinsic ...